JDS · Class II · 21 CFR 888.3030

FDA Product Code JDS: Nail, Fixation, Bone

FDA product code JDS covers bone fixation nails used in intramedullary and extramedullary fixation.

These implants provide axial stability across fracture sites and are used in the surgical treatment of long bone fractures, osteotomies, and fusions where nail-based fixation is preferred over plate or screw constructs.

JDS devices are Class II medical devices, regulated under 21 CFR 888.3030 and reviewed by the FDA Orthopedic panel.

Leading manufacturers include Smith & Nephew, Inc. and Narang Medical , Ltd..

53
Total
53
Cleared
96d
Avg days
1977
Since
Growing category - 3 submissions in the last 2 years vs 2 in the prior period
Review times increasing: avg 173d recently vs 91d historically

FDA 510(k) Cleared Nail, Fixation, Bone Devices (Product Code JDS)

53 devices
1–24 of 53

About Product Code JDS - Regulatory Context

510(k) Submission Activity

53 total 510(k) submissions under product code JDS since 1977, with 53 receiving FDA clearance (average review time: 96 days).

Submission volume has increased in recent years - 3 submissions in the last 24 months compared to 2 in the prior period - suggesting growing market activity in this device classification.

FDA Review Time

Recent submissions under JDS have taken an average of 173 days to reach a decision - up from 91 days historically. Manufacturers should account for longer review timelines in current project planning.

JDS devices are reviewed by the Orthopedic panel. Browse all Orthopedic devices →